- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02461602
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients (ELITE)
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Studieoversikt
Status
Forhold
Detaljert beskrivelse
ELITE will be a prospective, multicenter observational study of 500 participants to characterize demographics, comorbidities, risk profiles, socioeconomic status, and patient preferences related to anticoagulation management. The primary study endpoint will be warfarin discontinuation without resumption as documented in the medical record. Secondary outcomes of interest include warfarin adherence and factors associated with suboptimal adherence and/or permanent discontinuation. Clinical data, including demographics, medical history, and comorbidities, will be abstracted and entered by site coordinators. An internal survey developed by Duke Clinical Research Institute (DCRI) will be administered to patients during regularly scheduled clinic visits. Survey items will include patient treatment priorities, perceived risk of bleeding and/or stroke, barriers to adherence, and treatment satisfaction. Subjects will complete a survey at baseline and at the followup visit closest to 6 months after enrollment.
This study will provide the foundation for numerous potential future questions about medication adherence and barriers to treatment, such as a survey on physician preferences/ shared decision-making (concordance between physician and patient preferences), followup to capture clinical events, and interventions to improve long-term medication adherence in AF.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
California
-
Pasadena, California, Forente stater, 91105
- Foothill Cardiology
-
-
Florida
-
Coral Springs, Florida, Forente stater, 33065
- Holy Cross Medical Group
-
Port Charlotte, Florida, Forente stater, 33952
- Charlotte Heart Group
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30350
- Atlanta Institute for Medical Research, Inc.
-
Cumming, Georgia, Forente stater, 30041
- Atlanta Heart Specialists
-
-
Indiana
-
Munster, Indiana, Forente stater, 46321
- Cardiovascular Research of Northwest Indiana, L.L.C.
-
-
Kentucky
-
Owensboro, Kentucky, Forente stater, 42303
- Research Integrity, LLC.
-
-
Louisiana
-
New Orleans, Louisiana, Forente stater, 70121
- Ochsner Health System
-
-
Maine
-
Rockport, Maine, Forente stater, 04856
- Penobscot Bay Medical Center
-
-
Michigan
-
Alpena, Michigan, Forente stater, 49707
- Endeavor Medical Research
-
Saint Joseph, Michigan, Forente stater, 49085
- Great Lakes Heart and Vascular Institute
-
-
Minnesota
-
Saint Paul, Minnesota, Forente stater, 55102
- HealthEast Medical Research Institute
-
-
Mississippi
-
Jackson, Mississippi, Forente stater, 39216
- Jackson Heart Clinic
-
-
New Jersey
-
Elmer, New Jersey, Forente stater, 08318
- Cardiovascular Associates of the Delaware Valley
-
Voorhees, New Jersey, Forente stater, 08043
- Lourdes Cardiology Services
-
-
North Carolina
-
Lumberton, North Carolina, Forente stater, 28358
- Duke Cardiology of Lumberton
-
-
Pennsylvania
-
Doylestown, Pennsylvania, Forente stater, 18901
- Doylestown Health Cardiology
-
-
South Carolina
-
Columbia, South Carolina, Forente stater, 29203
- Columbia Heart Clinic, PA
-
-
Texas
-
Allen, Texas, Forente stater, 75013
- North Texas Research Associates
-
Waco, Texas, Forente stater, 76712
- Providence Health Center
-
-
Virginia
-
Newport News, Virginia, Forente stater, 23601
- Riverside Cardiology Specialists
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- 18 years or older at the time of enrollment
- Electrocardiographically confirmed AF
- Able to complete patient-reported outcomes surveys
- Initiated warfarin therapy in the prior 3 months
- Ability to adhere to regular clinical visits
- Ability to sign informed consent
- Ability to read/comprehend/speak English
Exclusion Criteria:
- Anticipated life expectancy less than six months (as determined by the site investigator)
- Transient AF secondary to a reversible condition (hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery)
- Recent Deep Venous Thrombosis(DVT) or Pulmonary Embolism (PE) (within 6 months)
- Participation in a randomized trial of anticoagulation for AF
- Use of a home international normalized ratio (INR) monitoring system
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Reason(s) for Warfarin discontinuation
Tidsramme: 6 months
|
6 months
|
Change in Warfarin adherence
Tidsramme: Baseline and 6 months
|
Baseline and 6 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Frequency of hospitalizations
Tidsramme: Baseline and 6 months
|
Baseline and 6 months
|
Frequency of bleeding events
Tidsramme: Baseline and 6 months
|
Baseline and 6 months
|
Change in INR values
Tidsramme: Baseline and 6 months
|
Baseline and 6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Emily O'Brien, PhD, DCRI
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Pro00061054
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Atrieflimmer
-
Pusan National University HospitalHar ikke rekruttert ennåHjerteimplanterbar elektronisk enhet | Atrial High Rate EpisodeKorea, Republikken
-
Helios Klinikum PforzheimRekrutteringHøyre hjertesvikt | Trikuspidal regurgitasjon | Hjerteombygging, Ventrikulær | Hjerteombygging, atrialTyskland
-
Henry Ford Health SystemTilbaketrukket
-
The Second Affiliated Hospital of Chongqing Medical...UkjentAtrieflimmer | Hjerteombygging, atrial | Sacubitril/Valsartan
-
W.L.Gore & AssociatesFullført
-
Nobles Medical Technologies II IncPåmelding etter invitasjonForamen Ovale, patent | Septal defekt, atrial | Septaldefekt, hjerteForente stater, Italia
-
HeartStitch.ComUkjentForamen Ovale, patent | Septal defekt, atrial | Septaldefekt, hjerteForente stater
-
China National Center for Cardiovascular DiseasesRekrutteringHjertesykdommer | Atrial septal dilatasjonKina
-
Universitair Ziekenhuis BrusselRekrutteringAtrial remodelleringBelgia
-
Amsterdam UMC, location VUmcRekruttering